Kidswell Bio Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
32
- Stock Symbol
-
4584
- Investments
-
5
- Share Price
-
$0.93
- (As of Friday Closing)
Kidswell Bio General Information
Description
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
Contact Information
Website
www.kidswellbio.comCorporate Office
- 3-8-3 Nihombashihoncho
- Chuo-ku
- Tokyo, 103-0023
- Japan
Corporate Office
- 3-8-3 Nihombashihoncho
- Chuo-ku
- Tokyo, 103-0023
- Japan
Kidswell Bio Stock Performance
As of 13-Nov-2026, Kidswell Bio’s stock price is $0.93. Its current market cap is $45.9M with 49.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.93 | $0.87 | $0.78 - $2.02 | $45.9M | 49.6M | 346K | -$0.05 |
Kidswell Bio Financials Summary
As of 30-Jun-2026, Kidswell Bio has a trailing 12-month revenue of $39.8M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 38,922 | 68,111 | 33,355 | 38,890 |
| Revenue | 39,756 | 43,722 | 33,325 | 16,826 |
| EBITDA | (2,380) | 757 | (9,557) | |
| Net Income | (2,417) | (2,747) | (139) | (9,842) |
| Total Assets | 37,860 | 38,086 | 46,835 | 33,601 |
| Total Debt | 15,284 | 15,952 | 12,282 | 17,014 |
Kidswell Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kidswell Bio Patents
Kidswell Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024237186-A1 | Pharmaceutical composition for preventing or treating refractory bone defects | Inactive | 12-May-2023 | ||
| JP-7804384-B2 | A novel population of dental pulp stem cells | Active | 03-Oct-2022 | ||
| EP-4599834-A1 | Agent for treating or preventing cerebral palsy | Pending | 03-Oct-2022 | ||
| EP-4599834-A4 | Agent for treating or preventing cerebral palsy | Pending | 03-Oct-2022 | ||
| WO-2024075676-A1 | Agent for treating or preventing cerebral palsy | Inactive | 03-Oct-2022 | A61K35/28 |
Kidswell Bio Signals
Kidswell Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kidswell Bio Investments & Acquisitions (5)
Kidswell Bio’s most recent deal was a Joint Venture with Alfenax Biologics. The deal was made on 01-Dec-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Alfenax Biologics | 01-Dec-2025 | Joint Venture | Drug Discovery | ||
| Heartseed | 11-Mar-2020 | Later Stage VC | Drug Discovery | ||
| Advanced Cell Technology and Engineering | 17-Jan-2019 | Merger/Acquisition | Other Healthcare Services | ||
| Advanced Cell Technology and Engineering | 30-Mar-2018 | Later Stage VC | Other Healthcare Services | ||
| OrthoReBirth | 27-Nov-2014 | Seed Round | Other Devices and Supplies |
Kidswell Bio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Kidswell Bio Exits (3)
Kidswell Bio’s most recent exit was on 11-Mar-2020 from Heartseed. The exit was categorized as with 8 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Heartseed | 11-Mar-2020 | Completed |
|
||
| Advanced Cell Technology and Engineering | 17-Jan-2019 | Completed |
|
||
| Advanced Cell Technology and Engineering | 30-Mar-2018 | Later Stage VC | Completed |
|
Kidswell Bio FAQs
-
When was Kidswell Bio founded?
Kidswell Bio was founded in 2001.
-
Where is Kidswell Bio headquartered?
Kidswell Bio is headquartered in Tokyo, Japan.
-
What is the size of Kidswell Bio?
Kidswell Bio has 32 total employees.
-
What industry is Kidswell Bio in?
Kidswell Bio’s primary industry is Biotechnology.
-
Is Kidswell Bio a private or public company?
Kidswell Bio is a Public company.
-
What is Kidswell Bio’s stock symbol?
The ticker symbol for Kidswell Bio is 4584.
-
What is the current stock price of Kidswell Bio?
As of 13-Nov-2026 the stock price of Kidswell Bio is $0.93.
-
What is the current market cap of Kidswell Bio?
The current market capitalization of Kidswell Bio is $45.9M.
-
What is Kidswell Bio’s current revenue?
The trailing twelve month revenue for Kidswell Bio is $39.8M.
-
What is Kidswell Bio’s annual earnings per share (EPS)?
Kidswell Bio’s EPS for 12 months was -$0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process